New personnel changes in our organization beginning 2025

We are pleased to announce significant personnel changes in our organization, which will come into effect at the beginning of 2025. These decisions are an important step towards the further development of Eubioco including increasing its ability to achieve ambitious commercial goals, but most importantly they are aimed at even more fruitful cooperation with our customers.

  • As of January 1, 2025, Sylwia Tobólska, already working in our organization, has taken up a new position as Director of Commercial Affairs, Research and Development and will join the Board of Directors of Galenowe Laboratory Olsztyn. Sylwia, who has been involved in the pharmaceutical industry for more than 20 years, combines extensive knowledge in research and development with experience in business relations. The combination of her competence and responsibility for the sales area will allow us to achieve the goals of our organization even more effectively. We believe that her leadership will strengthen the cooperation between Product Development and Sales, which will translate into increased efficiency of operations and satisfaction of our customers.
  • On January 2, 2025, Marcin Korzeniowski joined our team, assuming the position of Key Account Executive Team Leader. Marcin brings to Eubioco more than 10 years of experience in the pharmaceutical industry and a successful track record in managing teams and developing business relationships. His prior experience and practical knowledge will be a tremendous asset in executing our strategic plans.

We are confident that the new structure will allow us to respond more effectively to the needs of our customers and achieve our ambitious development goals.

On behalf of the entire organization, we congratulate Sylwia and Marcin wishing them good luck in their new roles🙂 !